跳至主要内容
临床试验/NCT03942770
NCT03942770进行中(未招募)不适用

Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement With an Underserved Population

Mikhail N Koffarnus4 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2019年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
91
试验地点
4
主要终点
Pattern of abstinence from alcohol during intervention

研究概览

简要总结

Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. As our feasibility study demonstrates, remote breathalyzer monitoring drastically improves the practicality of delivering an alcohol contingency management intervention. In Experiment 2, we will test whether the addition of remote abstinence incentives to treatment as usual improves outpatient treatment outcomes and prevents relapse following inpatient detoxification at a regional hospital system. We will also assess whether readmission rates are reduced using a newly developed smartphone app and breathalyzer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recently completed or currently completing an alcohol detoxification program through the Carilion Clinic or University of Kentucky Healthcare system.
  • Meet DSM-V criteria for alcohol use disorder.
  • Abstinent from alcohol at the time of consent.

排除标准

  • Alcohol use disorder is secondary to another substance use disorder.

研究组 & 干预措施

Active Comparator: Group A (Intensive incentives)

Active Comparator

Group A will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will also have the opportunity to earn more incentives for providing negative results. For the first 3 weeks, these additional incentives will scale based on the number of consecutive days of sustained negative samples. For the remaining weeks incentives will be based on a randomized "prize" drawing.

干预措施: Contingency Management (Behavioral)

Active Comparator: Group B (Prize-based incentives)

Active Comparator

Group B will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will only have the opportunity to earn more incentives based on a randomized "prize" drawing if they submit a negative sample.

干预措施: Contingency Management (Behavioral)

Sham Comparator: Group C (Intensive incentives)

Sham Comparator

Group C serves as a direct control group to Group A and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.

干预措施: Contingency management (Behavioral)

Sham Comparator: Group D (Price-based incentives)

Sham Comparator

Group D serves as a direct control group to Group B and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.

干预措施: Contingency management (Behavioral)

No Intervention: Group E (no incentives)

No Intervention

Group E will have no monitoring intervention, they will only complete assessment sessions.

结局指标

主要结局

Pattern of abstinence from alcohol during intervention

时间窗: up to 66 weeks

Breathalyzer assessments will be collected during the treatment period. This outcome measure will consist of the percentage of days without alcohol use as detected by the breathalyzers.

Time to relapse

时间窗: A total of 12 assessment sessions spanning over a 66 week period

For this outcome, we will conduct survival analyses to compare relapse across study groups.

Treatment acceptability

时间窗: A total of 12 assessment sessions spanning over a 66 week period

Participant ratings of treatment acceptability on a customized Treatment Acceptability questionnaire will be collected during assessment sessions. Each question will be scored from 1 (low) to 4 (high) and will assess distinct components of the treatment. Questions will be interpreted and scored individually and not be summed together.

次要结局

未报告次要终点

研究者

发起方
Mikhail N Koffarnus
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mikhail N Koffarnus

Associate Professor

University of Kentucky

研究点 (4)

Loading locations...

相似试验